☆ 4.6 Article

Predictive factors of a viral neutralizing humoral response after a third dose of COVID-19 mRNA vaccine

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Rheumatology

Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease

David Simon et al.

Summary: The study found that a third vaccination in IMID patients who did not respond to standard vaccination can induce protective immunity. Seroconversion and neutralising activity were higher in non-RTX patients compared to RTX-treated patients. T cell responses did not significantly impact vaccination efficacy.

ANNALS OF THE RHEUMATIC DISEASES (2022)

添加到收藏夹

Review Urology & Nephrology

Humoral and cellular immune response to severe acute respiratory syndrome coronavirus-2 vaccination in haemodialysis and kidney transplant patients

Joel Swai et al.

Summary: This study examined the immune response proportions of end-stage renal disease patients on renal replacement therapy after receiving COVID-19 vaccines. The findings showed that hemodialysis and kidney transplant patients had lower immune response proportions compared to healthy controls, with hemodialysis patients showing improvement over time, while kidney transplant patients remained significantly lower throughout the four weeks. The one-size-fits-all vaccination scheme may not be adequate for kidney transplant patients.

NEPHROLOGY (2022)

添加到收藏夹

Article Surgery

Is COVID-19 infection more severe in kidney transplant recipients?

Sophie Caillard et al.

Summary: Transplant recipients had a higher COVID-19-related mortality compared to nontransplant hospitalized patients but did not differ significantly in the rate of severe disease. Factors associated with severe COVID-19 included age, cardiovascular disease, dyspnea, fever, lymphopenia, and CRP.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Shuo Feng et al.

Summary: Defined levels of SARS-CoV-2-specific binding and neutralizing antibodies elicited by the COVID-19 vaccine were identified as correlates of protection against symptomatic infection. Higher levels of immune markers were correlated with a reduced risk of symptomatic infection. The data can be used to extrapolate efficacy estimates to new populations.

NATURE MEDICINE (2021)

添加到收藏夹

Editorial Material Urology & Nephrology

COVID-19 vaccination in kidney transplant recipients

Sophie Caillard et al.

Summary: Kidney transplant recipients, due to therapeutic immunosuppression, have impaired immune responses to the COVID-19 mRNA vaccine, necessitating a personalized intensified vaccination approach for better protection.

NATURE REVIEWS NEPHROLOGY (2021)

添加到收藏夹

Letter Medicine, General & Internal

Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines

Ai-ris Y. Collier et al.

Summary: The kinetics of immune response to Covid-19 vaccines were studied, showing varying peak levels and durations of response for different vaccines. However, the response levels correlating with protection have not been defined yet.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Letter Surgery

COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination

Hani M. Wadei et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

添加到收藏夹

Article Surgery

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus

Ayelet Grupper et al.

Summary: Only 37.5% of transplant recipients developed a positive immune response to the Pfizer vaccine, with lower antibody levels, and factors associated with null immune response include older age, high-dose corticosteroids use, triple immunosuppression maintenance, and regimen with mycophenolate.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

添加到收藏夹

Article Medical Laboratory Technology

Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers

Andrea Padoan et al.

Summary: The study evaluated the analytical and clinical performance of a SARS-CoV-2 RBD IgG assay and found a strong correlation between the antibody levels and neutralizing activity, with a sensitivity of 99.0% and specificity of 92.5% when tested 14 days post infection.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

添加到收藏夹

Article Infectious Diseases

Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study

Benaya Rozen-Zvi et al.

Summary: Kidney transplant recipients showed a low antibody response rate of 36.4% after receiving the SARS-CoV-2 mRNA vaccine. Factors associated with antibody response include estimated glomerular filtration rate, medication dosage, age, and calcineurin inhibitor blood level.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety and Cross-Variant Immunogenicity of a Three-dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients

Filippo Massa et al.

Summary: A three-dose regimen of the BNT162b2 COVID-19 vaccine significantly improves anti-spike IgG levels, neutralizing antibodies, and cellular immune responses in kidney transplant recipients with a tolerable tolerability profile.

EBIOMEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

添加到收藏夹

Letter Immunology

Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept

Nathalie Chavarot et al.

TRANSPLANTATION (2021)

添加到收藏夹

Article Virology

Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)

Johannes Korth et al.

Summary: Research has shown that renal transplant recipients have impaired immune response after receiving two doses of mRNA-based vaccine, with significantly lower antibody levels compared to healthy controls.

VIRUSES-BASEL (2021)

添加到收藏夹

Letter Urology & Nephrology

Postvaccine Anti-SARS-CoV-2 Spike Protein Antibody Development in Kidney Transplant Recipients

Syed Ali Husain et al.

KIDNEY INTERNATIONAL REPORTS (2021)

添加到收藏夹

Article Surgery

Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients

David Cucchiari et al.

Summary: The study on 148 kidney transplant recipients showed that the mRNA SARS-CoV-2 vaccine elicited either cellular or humoral response in 65.0% of the patients. Approximately 20.9% of patients were considered to have prior immunization against SARS-CoV-2, while 79.1% were deemed naïve to the virus.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

添加到收藏夹

Letter Medicine, General & Internal

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

William A. Werbel et al.

ANNALS OF INTERNAL MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses

Ilies Benotmane et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Urology & Nephrology

Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients

Clement Danthu et al.

Summary: The study shows that kidney transplant recipients have a strong inhibition of humoral response to COVID-19 vaccination due to immunosuppressant therapy, while patients undergoing hemodialysis have lower antibody levels. Factors such as age, serum albumin, and Kt/V can impact the level of antibody response.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

添加到收藏夹

Letter Urology & Nephrology

Occurrence of severe COVID-19 in vaccinated transplant patients

Sophie Caillard et al.

KIDNEY INTERNATIONAL (2021)

添加到收藏夹

Letter Urology & Nephrology

Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine

Ilies Benotmane et al.

KIDNEY INTERNATIONAL (2021)

添加到收藏夹

Letter Medicine, General & Internal

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

Nassim Kamar et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19

M. P. O'Brien et al.

Summary: The study indicates that subcutaneous REGEN-COV can effectively prevent severe Covid-19 and reduce the duration of symptoms in individuals at high risk for infection due to household exposure to confirmed SARS-CoV-2 cases.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Letter Immunology

Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant

Julian Stumpf et al.

TRANSPLANTATION (2021)

添加到收藏夹

Letter Immunology

Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination

Nicole M. Ali et al.

TRANSPLANTATION (2021)

添加到收藏夹

Letter Immunology

Low Immunization Rate in Kidney Transplant Recipients Also After Dose 2 of the BNT162b2 Vaccine: Continue to Keep Your Guard up!

Karsten Midtvedt et al.

TRANSPLANTATION (2021)

添加到收藏夹

Article Immunology

Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients

Hector Rincon-Arevalo et al.

Summary: Patients with kidney failure are at increased risk for SARS-CoV-2 infection, making effective vaccination critical. However, studies have found significantly impaired antibody responses to the BNT162b2 vaccine in kidney transplant recipients and dialysis patients, leading to insufficient immune responses.

SCIENCE IMMUNOLOGY (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients

Arne Sattler et al.

Summary: The study analyzed immune responses in kidney transplant recipients after receiving the BNT162b2 vaccine, finding weaker antibody responses in transplant patients compared to healthy individuals and most hemodialysis patients. Additionally, spike-specific T cell responses were significantly reduced in transplant patients, indicating a need for revised vaccination strategies in immunosuppressed individuals.

JOURNAL OF CLINICAL INVESTIGATION (2021)

添加到收藏夹

Article Immunology

Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum

Stuart P. Weisberg et al.

Summary: This study found distinct antibody responses in children and adults after SARS-CoV-2 infection. Adult COVID-19 cohorts showed a broader range of antibody responses, while children predominantly generated antibodies specific for the S protein and had reduced neutralizing activity compared to adults.

NATURE IMMUNOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J. Williamson et al.

NATURE (2020)

添加到收藏夹

Article Urology & Nephrology

Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe

Kitty J. Jager et al.

KIDNEY INTERNATIONAL (2020)

添加到收藏夹

Article Urology & Nephrology

An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants

Sophie Caillard et al.

KIDNEY INTERNATIONAL (2020)

添加到收藏夹

Article Urology & Nephrology

IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)

Olivier Thaunat et al.

KIDNEY INTERNATIONAL (2020)

添加到收藏夹

Article Immunology

Residual Activatability of Circulating Tfh17 Predicts Humoral Response to Thymodependent Antigens in Patients on Therapeutic Immunosuppression

Suzan Dahdal et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Article Immunology

CD4+T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression

Chien-Chia Chen et al.

FRONTIERS IN IMMUNOLOGY (2018)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.